MLCPX
Price
$8.32
Change
+$0.03 (+0.36%)
Updated
Oct 7 closing price
Net Assets
762.26M
MLPMX
Price
$4.69
Change
+$0.03 (+0.64%)
Updated
Oct 7 closing price
Net Assets
281M
Interact to see
Advertisement

MLCPX vs MLPMX

Header iconMLCPX vs MLPMX Comparison
Open Charts MLCPX vs MLPMXBanner chart's image
MainGate MLP C
Price$8.32
Change+$0.03 (+0.36%)
VolumeN/A
Net Assets762.26M
Invesco SteelPath MLP Alpha Plus C
Price$4.69
Change+$0.03 (+0.64%)
VolumeN/A
Net Assets281M
MLCPX vs MLPMX Comparison Chart in %
View a ticker or compare two or three
VS
MLCPX vs. MLPMX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLCPX is a Buy and MLPMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MLCPX has more cash in the bank: 762M vs. MLPMX (281M). MLPMX pays higher dividends than MLCPX: MLPMX (6.80) vs MLCPX (5.23). MLCPX was incepted earlier than MLPMX: MLCPX (12 years) vs MLPMX (13 years). MLCPX (12.21) is less costly to investors than MLPMX (8.81). MLPMX is a more actively managed with annual turnover of: 26.00 vs. MLCPX (15.31). MLPMX has a lower initial minimum investment than MLCPX: MLPMX (1000) vs MLCPX (2500). MLPMX annual gain was more profitable for investors over the last year : 6.82 vs. MLCPX (5.27). MLPMX return over 5 years is better than : 368.56 vs. MLCPX (258.48).
MLCPXMLPMXMLCPX / MLPMX
Total Expense Ratio12.218.81139%
Annual Report Gross Expense Ratio12.218.81139%
Fund Existence12 years13 years-
Gain YTD-0.568-1.07153%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets762M281M271%
Annual Yield % from dividends5.236.8077%
Returns for 1 year5.276.8277%
Returns for 3 years70.2895.8573%
Returns for 5 years258.48368.5670%
Returns for 10 years58.8251.61114%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABEMX17.55N/A
N/A
abrdn Emerging Markets Instl
BIPSX27.61N/A
N/A
ProFunds Biotechnology UltraSector Svc
JHTAX20.45N/A
N/A
JPMorgan Hedged Equity 3 A
MATFX18.00N/A
N/A
Matthews Asia Innovators Investor
JHQRX34.75N/A
N/A
JPMorgan Hedged Equity R6